Analysis for transcriptional regulation of the BCL6 gene
Analysis for transcriptional regulation of the BCL6 gene
批准号:
09671098
负责人:
MIKI Tohru
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rearrangements of the BCL6 gene have been frequently found in human B-cell lymphomas, as a result of reciprocal chromosomal translocation involving band 3q27. Chromosomal breaks preferentially occur within a 3-kb region containing the first exon and intron of thh BCL6 gene. Recent reports revealed that internal deletions or point mutations within this limited region are also common in B-cell lymphomas. These observations suggest that the structural alteration of the first exon-intron boundary region of the BCL6 gene, a putative regulatory region, may be crucial event in the development of B-cell lymphomas. To further understand the mechanism of the deregulated expression of BCL6 in lymphomas, we investigated the physiological function of this region in transcriptional regulation of the BCL6 gene.Through luciferase reporter assay using B-cell line Raji, we have identified two regions that negatively regulate BCL6 expression. One region designated as ES located within the first exon betw … More een nucleotides +472 and +543, and the other region designated as IS between +783 and +918 of the first intron. Consensus nucleotide sequence for a binding of BCL6 protein itself was found within the ES region. Subsequent electrophoretic mobility shift assay revealed an actual binding of BCL6 to the ES region. Co-transfection experiment using a BCL6 expression vector showed that transcription of the BCL6 gene was partly regulated by a negative feedback of the BCL6 gene product.Another negative regulatory region IS has been shown to have a silencer activity. The IS region is entirely included in the regions commonly deleted in B-cell lymphomas as well as in the parts where somatic hypermutations are found in both normal and neoplastic B-cells. Electrophoretic mobility shift assay showed that the nuclear proteins that specifically bind to this intronic silencer element are expressed in several hematopoietic cell lines.Taken together, the identified regions of the BCL6 gene contain negative regulatory elements and the structural alterations of these regions have potential roles in the deregulated expression of the BCL6 gene in B-cell lymphomas. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ichinohazama,R et al.: "Translocation (3;16)(q27;11) ina patient with diffuse large B-cell lymphoma associated with the BCL6 gene rearrangement" Cancer Creast.Cytogenet.103-2. 133-139 (1998)
Ichinohazama,R 等人:“与 BCL6 基因重排相关的弥漫性大 B 细胞淋巴瘤患者的易位 (3;16)(q27;11)”Cancer Crest.Cytogenet.103-2。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohshima,A et al.: "Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Halzin's lymphoma" Laukemia Lymphoma. 27. 329-334 (1997)
Ohshima,A 等人:“54 名非哈尔津淋巴瘤患者中影响 3q27 的 BCL6 基因重排和染色体畸变”白血病淋巴瘤。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Adra,CN et al.: "Variants of B cell lymphoma 6(BCL6) and marked atopy" Clinical Genetics. 54・4. 362-364 (1998)
Adra, CN 等人:“B 细胞淋巴瘤 6 (BCL6) 变异和显着特应性”临床遗传学 54・4 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kumagai, T.et al.: "The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells" Oncogene. 18(2). 467-475 (1999)
Kumagai, T.et al.:“原癌基因 Bc16 抑制分化诱导的小鼠肌原细胞中的凋亡细胞死亡”Oncogene。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fukuda,T et al.: "Disruption of the BLC6 gene results in an impaired germinal center formation" J.Exp.Med.186. 439-448 (1997)
Fukuda,T 等人:“BLC6 基因的破坏导致生发中心形成受损”J.Exp.Med.186。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Functional modification of the transcription factor BCL6 by acetylation
-
批准号:14570966
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:MIKI Tohru
-
依托单位:
THE SIGNIFICANCE OF CHROMOSOMAL TRANSLOCATION INVOLVING BCL6 GENE IN MALIGNANT LYMPHOMA
-
批准号:12670977
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MIKI Tohru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
-
批准号:82371478
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:焦英甫
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
-
批准号:82372327
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马展
-
依托单位:
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
-
批准号:81172109
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:柳凤亭
-
依托单位:
microRNA-21靶向的肿瘤反义基因显像研究
-
批准号:81101065
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:康磊
-
依托单位:
Thalidomide增强temozolomide对恶性胶质瘤治疗作用潜在机理的研究
-
批准号:30772228
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:杨学军
-
依托单位:
携带CD-UPRT双功能基因的内皮祖细胞载体靶向治疗恶性胶质瘤的实验研究
-
批准号:30571904
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:杨学军
-
依托单位: